Akebia Therapeutics, Inc.
AKBA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69 | -$52 | -$93 | -$282 |
| Dep. & Amort. | $38 | $42 | $38 | $36 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $9 | $18 | $0 |
| Change in WC | -$40 | -$21 | -$1 | -$106 |
| Other Non-Cash | $23 | -$2 | -$35 | $99 |
| Operating Cash Flow | -$41 | -$23 | -$73 | -$253 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $40 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $0 | -$0 | $40 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $8 | -$32 | -$33 | $45 |
| Stock Issued | $43 | $7 | $8 | $89 |
| Stock Repurch. | -$1 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $40 | $0 |
| Financing Cash Flow | $50 | -$25 | $15 | $134 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $9 | -$49 | -$59 | -$79 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45 | $93 | $152 | $229 |
| End Cash | $54 | $45 | $93 | $150 |
| Free Cash Flow | -$41 | -$23 | -$73 | -$253 |